Use of conservative management for low-risk prostate cancer in the veterans affairs integrated health care system from 2005-2015

JAMA - Journal of the American Medical Association

Volumn 319, Issue 21, 2018, Pages 2231-2233

  Loeb, Stacy ^a   Byrne, Nataliya ^b   Makarov, Danil V ^a   Lepor, Herbert ^b   Walter, Dawn ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BLACK PERSON; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER THERAPY; COMORBIDITY; CONSERVATIVE TREATMENT; FOLLOW UP; HIGH VOLUME HOSPITAL; HUMAN; INTEGRATED HEALTH CARE SYSTEM; LETTER; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIDDLE AGED; PROSTATE BIOPSY; PROSTATE CANCER; SHARED DECISION MAKING; VETERAN; WATCHFUL WAITING; BLOOD; GOVERNMENT; MULTIVARIATE ANALYSIS; PROSTATE TUMOR; RISK FACTOR; STATISTICAL MODEL; TRENDS; UNITED STATES; UTILIZATION;

AGED; CONSERVATIVE TREATMENT; DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS; WATCHFUL WAITING;

EID: 85048256340     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.5616     Document Type: Letter

References (6)

1. Chen RC, Rumble RB, Loblaw DA, et al. Active surveillance for the management of localized prostate cancer (Cancer Care Ontario Guideline). J Clin Oncol. 2016;34(18):2182-2190.
2. Cooperberg MR, Carroll PR. Trends in management for patients with localized prostate cancer, 1990-2013. JAMA. 2015;314(1):80-82.
3. Moschini M, Fossati N, Sood A, et al. Contemporary management of prostate cancer patients suitable for active surveillance. Eur Urol Focus. doi:10.1016/j.euf.2016.06.001
4. Loeb S, Folkvaljon Y, Curnyn C, Robinson D, Bratt O, Stattin P. Uptake of active surveillance for very-low-risk prostate cancer in Sweden. JAMA Oncol. 2017;3(10):1393-1398.
5. Loeb S, Curnyn C, Fagerlin A, et al. Qualitative study on decision-making by prostate cancer physicians during active surveillance. BJU Int. 2017;120(1):32-39.
6. Auffenberg GB, Lane BR, Linsell S, Cher ML, Miller DC. Practice- vs physician-level variation in use of active surveillance for men with low-risk prostate cancer. JAMA Surg. 2017;152(10):978-980.